Targeting mTOR Signaling Pathway in Ovarian Cancer

E-ISSN： 1875-533x|18|19|2960-2968

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.18, Iss.19, 2011-06, pp. : 2960-2968

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

mTOR Pathway and mTOR Inhibitors as Agents for Cancer Therapy

Current Cancer Drug Targets, Vol. 8, Iss. 8, 2008-12 ,pp. : 647-665

Bentham Science Publishers

Access to resources Recommend Favorite

Insights into melanoma: targeting the mTOR pathway for therapeutics

By Pópulo Helena Soares Paula Lopes José Manuel

Expert Opinion on Therapeutic Targets, Vol. 16, Iss. 7, 2012-07 ,pp. : 689-705

Informa Healthcare

Access to resources Recommend Favorite

Targeting the mTOR Pathway in Tumor Malignancy

Current Cancer Drug Targets, Vol. 13, Iss. 3, 2013-03 ,pp. : 267-277

Bentham Science Publishers

Access to resources Recommend Favorite

An overview of the mTOR pathway as a target in cancer therapy

By Gentzler Ryan D Altman Jessica K Platanias Leonidas C

Expert Opinion on Therapeutic Targets, Vol. 16, Iss. 5, 2012-05 ,pp. : 481-489

Informa Healthcare

Access to resources Recommend Favorite

The mTOR Pathway: A New Target in Cancer Therapy

Current Cancer Drug Targets, Vol. 10, Iss. 5, 2010-08 ,pp. : 484-495

Bentham Science Publishers

Access to resources Recommend Favorite